September 6, 2022 In puma-tarihleme yorumlar
Prince HM, Kim YH, Horwitz SM, Dummer R, Scarisbrick J, Quaglino P, et al
Prince HM, Kim YH, Horwitz SM, Dummer R, Scarisbrick J, Quaglino P, et al 147. Brentuximab vedotin otherwise doctor’s options for the CD30-positive cutaneous T-telephone lymphoma (ALCANZA): a global, open-term,